Cargando…

Nephrogenic Systemic Fibrosis: Mini-Review

Detalles Bibliográficos
Autores principales:	Mundim, Juliano Sacramento, de Castro Lorena, Sabrina, Elias, Rosilene Motta, Júnior, João Egídio Romão
Formato:	Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694254/ https://www.ncbi.nlm.nih.gov/pubmed/19488616 http://dx.doi.org/10.1590/S1807-59322009000500017

Ejemplares similares

Nephrogenic systemic fibrosis (NSF): the role of tamoxifen
por: Davison, Rachel, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis
por: Braverman, Irwin M, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis
por: Madke, Bhushan, et al.
Publicado: (2011)

Nephrogenic systemic fibrosis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Understanding Nephrogenic Systemic Fibrosis
por: Chopra, Tushar, et al.
Publicado: (2012)

NEPHROGENIC SYSTEMIC FIBROSIS: A BRIEF REVIEW
por: Waikhom, Rajesh, et al.
Publicado: (2011)

NEPHROGENIC SYSTEMIC FIBROSIS: TIME FOR THE REQUIEM?
por: Panda, Saumya
Publicado: (2011)

NEPHROGENIC SYSTEMIC FIBROSIS: CURRENT CONCEPTS
por: Basak, Prasanta, et al.
Publicado: (2011)

Congenital nephrogenic diabetes insipidus with end-stage renal disease
por: Ryu, Hyun Ho, et al.
Publicado: (2015)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
por: Hanna, Robert F., et al.
Publicado: (2014)

Nephrogenic systemic fibrosis: A frivolous entity
por: Bhargava, Vinant, et al.
Publicado: (2021)

Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
por: Pieringer, Herwig, et al.
Publicado: (2008)

NEPHROGENIC SYSTEMIC FIBROSIS: REVIEW OF 408 BIOPSY-CONFIRMED CASES
por: Zou, Zhitong, et al.
Publicado: (2011)

Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
por: Mendichovszky, Iosif A., et al.
Publicado: (2007)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis
por: Ustuner, Pelin, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
por: Elmholdt, Tina R., et al.
Publicado: (2013)

Lack of MRI neurohypophyseal bright signal in a child with congenital nephrogenic diabetes insipidus
por: Chehade, Hassib, et al.
Publicado: (2010)

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016
por: Endrikat, Jan, et al.
Publicado: (2018)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
por: Reiter, Theresa, et al.
Publicado: (2012)

Correction: Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
Publicado: (2014)

Neuroleptic Malignant Syndrome in a Patient with Lithium-induced Nephrogenic Diabetes Insipidus: A Case Report
por: Ng, Bee Zhen, et al.
Publicado: (2021)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
por: Bennett, Charles L., et al.
Publicado: (2012)

Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis
por: Zhang, Ranran, et al.
Publicado: (2017)

Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation
por: Fuah, Kar Wah, et al.
Publicado: (2017)

Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019)

Prevalence and imaging features of nephrogenic systemic fibrosis at two large medical centers
por: Prince, Martin R, et al.
Publicado: (2009)

Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis
por: O'Donnell, Patrick J, et al.
Publicado: (2008)

The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
por: Crowley, Anna Lisa, et al.
Publicado: (2012)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager
por: Gallo-Bernal, Sebastian, et al.
Publicado: (2022)

The Clinical Manifestations and Efficacy of Different Treatments Used for Nephrogenic Systemic Fibrosis: A Systematic Review
por: Farooqi, Shaheer, et al.
Publicado: (2023)

Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis
por: Bose, Chhanda, et al.
Publicado: (2015)

Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review
por: Lange, Sandra, et al.
Publicado: (2021)

Ankle-Brachial Index: A Simple Way to Predict Mortality among Patients on Hemodialysis - A Prospective Study
por: Jimenez, Zaida Noemy Cabrera, et al.
Publicado: (2012)

A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
por: Do, Jong Geol, et al.
Publicado: (2012)

An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis
por: Zhang, Bin, et al.
Publicado: (2015)

Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis
por: Gordon, Emily R., et al.
Publicado: (2023)

Selected renal cells harbor nephrogenic potential
por: Narayan, Prakash, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hq587tpchptoo4h0omrnh58tk